In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS 

No. 16-1320V 

(not to be published) 

* * * * * * * * * * * * * * * * * * * * * * * * * 

RANDY BLAIR DAVIS, * 

 * Special Master Corcoran 

 * 

 Petitioner, * Filed: July 28, 2017 

 * 

 v. * 

 * Decision by Stipulation; Damages; 

SECRETARY OF HEALTH * Influenza (“Flu”) Vaccine; 

AND HUMAN SERVICES, * Post-Vaccine Syndrome with Demyelinating 

 * Features. 

 Respondent. * 

 * 

* * * * * * * * * * * * * * * * * * * * * * * * * 

 

Nancy R. Meyers, Ward Black Law, Greensboro, NC, for Petitioner. 

Claudia B. Gangi, U.S. Dep’t of Justice, Washington, DC, for Respondent. 

DECISION AWARDING DAMAGES1

On October 11, 2016, Randy Blair Davis filed a petition seeking compensation under the 

National Vaccine Injury Compensation Program (“Vaccine Program”).2

 Petitioner alleges that he 

suffered from a post-vaccine syndrome with demyelinating features as a result of his October 28, 

2014, influenza (“flu”) vaccine. Petitioner further alleges that he has experienced the residual 

effects of this condition for more than six months. 

 

1

 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the 

Court of Federal Claims’s website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This 

means the ruling will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. 

Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any 

information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged 

or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly 

unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision in its present form will be 

available. Id. 

2

 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 

100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). 
2 

Respondent denies that the flu vaccine caused Petitioner’s post-vaccine syndrome with 

demyelinating features or any other injuries. Nonetheless both parties, while maintaining their 

above-stated positions, agreed in a stipulation (filed on July 27, 2017) that the issues before them 

could be settled, and that a decision should be entered awarding Petitioner compensation. 

I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation 

(as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the 

terms set forth therein. 

The stipulation awards: 

 A lump sum of $70,000.00 in the form of a check payable to Petitioner. 

Stipulation ¶ 8. This amount represents compensation for all damages that would be available 

under Section 15(a) of the Act. 

I approve a Vaccine Program award in the requested amount set forth above to be made to 

Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of 

the Court is directed to enter judgment herewith.3

IT IS SO ORDERED. 

 

 /s/ Brian H. Corcoran

 Brian H. Corcoran 

 Special Master 

 

3

 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) 

a notice renouncing their right to seek review.